Log in
Blog
Contact Us
(877) 406-8636
Log in

Delta Dawn: An overview of the legal landscape regarding cannabis sativa and the future of legal cannabis

Joanne Hawana
Joanne Hawana
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C

Joanne counsels’ global clients on regulatory and distribution-related considerations to bringing a new FDA-regulated product to market and how to ensure continued compliance after a product is commercialized, including with respect to advertising and promotion.

Jane Haviland
Jane Haviland
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C

Jane’s practice focuses primarily on health care enforcement defense. Jane defends laboratories, physicians, and other clients facing government investigations and qui tam litigation arising from alleged violations of the federal False Claims Act (FCA), the Stark Law, and alleged criminal and civil violations of the anti-kickback statute.

Live Video-Broadcast: May 9, 2024
Delta Dawn: An overview of the legal landscape regarding cannabis sativa and the future of legal cannabis

$195.00 1.5 hour CLE

MCLE Credit Information:

Select Your State Below to View CLE Credit Information

Can't Decide Which CLE Program?

Access All
myLawCLE Programs
Only $395yr

Annual Subscription includes access to:
  • 500+ Live CLE Webinars
  • National Hot Legal Topics
  • New Laws and Regulations
  • State Specific Programs
  • All Formats: Live, Replay, & On-Demand
Subscribe Today
Training 5 or more people?

Sign-up for a law firm subscription plan and each attorney in the firm receives free access to all CLE Programs

Law Firm Subscription Plan

Program Summary

This CLE will address the legality of various cannabinoids pursuant to the federal Controlled Substances Act, the federal Agriculture Improvement Act of 2018 (the “Farm Bill”), and state regulatory frameworks. We will examine prospective changes to the laws governing delta-9 THC and hemp, federal and state enforcement trends, and the future of the cannabis and intoxicating hemp industries.

Key topics to be discussed:

  • An understanding of cannabinoids
  • The federal regulatory framework, including the Controlled Substances Act, Farm Bill, and the role of the Drug Enforcement Agency and Food and Drug Administration
  • The state regulatory framework, including states where medical and recreational cannabis programs exist and states where regulators have begun to address intoxicating hemp
  • Federal and state enforcement
  • Federal preemption issues

Date / Time: May 9, 2024

  • 12:00 pm – 1:40 pm Eastern
  • 11:00 am – 12:40 pm Central
  • 10:00 am – 11:40 am Mountain
  • 9:00 am – 10:40 am Pacific

Closed-captioning available

Speakers

Joanne Hawana_myLawCLEJoanne Hawana | Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C

Joanne counsels’ global clients on regulatory and distribution-related considerations to bringing a new FDA-regulated product to market and how to ensure continued compliance after a product is commercialized, including with respect to advertising and promotion. She also advises on the business impact of new US federal and state actions that affect those regulated products, such as drugs, biologics, regenerative medicine products, foods, cosmetics, and medical devices, including in vitro diagnostics, lab tests, and mobile medical applications.

 

Jane Haviland_myLawCLEJane Haviland | Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C

Jane’s practice focuses primarily on health care enforcement defense. Jane defends laboratories, physicians, and other clients facing government investigations and qui tam litigation arising from alleged violations of the federal False Claims Act (FCA), the Stark Law, and alleged criminal and civil violations of the anti-kickback statute. Jane assists clients with negotiation and structuring of global settlements with the US Department of Justice and its US Attorneys’ Offices and state Attorneys’ General Offices as well as corporate integrity agreements with the Department of Health and Human Services Office of Inspector General. Jane also defends clients in consumer protection and unfair or deceptive trade practices investigations initiated by the Federal Trade Commission or state Attorneys’ General Offices. Jane also advises clients regarding cannabis licensing, compliance, and regulatory matters.

Agenda

I. An understanding of cannabinoids | 12:00pm – 12:20pm

II. The federal regulatory framework, including the Controlled Substances Act, Farm Bill, and the role of the Drug Enforcement Agency and Food and Drug Administration | 12:20pm – 12:40pm

III. The state regulatory framework, including states where medical and recreational cannabis programs exist and states where regulators have begun to address intoxicating hemp | 12:40pm – 1:00pm

Break | 1:00pm – 1:10pm

IV. Federal and state enforcement | 1:10pm – 1:25pm

V. Federal preemption issues | 1:25pm – 1:40pm

Other Webinars You May Like